Abstract
Abstract. The study aims to analyze the course of SARS-CoV-2 infection and age-associated therapeutic comor-bidities in groups of elderly patients in order to detect their interrelation and determine the diagnosis. Based on the data obtained from domestic and foreign literature on redictors of SARS-CoV-2 severity, indications for in-patient treatment, textbooks on resuscitation, outcomes, and age-associated and comorbid factors of its course, the authors examined clinical and epidemiological indicators of 22,628 patients with acute stages of moderate, severe, and extremely severe course of SARS-CoV-2, including 772 patients with long COVID, who underwent treatment in post-COVID hospital from 2020 to 2022. The study shows that during the SARS-CoV-2 pandemic, many residents of the region required hospitalization as well as admission to intensive care departments. In addition to that, elderly patients, especially those with metabolically associated pathology, form a group of patients with a high risk of a severe course of the disease, which worsens the patient’s state in accordance with the complications’ development. Thus, these patients required a special approach to the algorithm of treatment and diagnosis with an analysis of all clinical and epidemiological gerontological aspects of novel infection and the relation between the course and the outcome of the disease in patients with comorbidities.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.